Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 74,485 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 74,485 shares of the firm’s stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $67.53, for a total transaction of $5,029,972.05. Following the completion of the sale, the chief executive officer now directly owns 5,458,502 shares of the company’s stock, valued at approximately $368,612,640.06. This represents a 1.35 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Tempus AI Stock Performance

Shares of Tempus AI stock traded up $3.97 during trading hours on Friday, hitting $68.96. The company’s stock had a trading volume of 16,292,734 shares, compared to its average volume of 11,766,354. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a 50 day moving average price of $44.36 and a two-hundred day moving average price of $48.84. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49.

Institutional Investors Weigh In On Tempus AI

A number of institutional investors have recently added to or reduced their stakes in the stock. Kovitz Investment Group Partners LLC purchased a new stake in shares of Tempus AI during the 3rd quarter worth approximately $1,367,000. China Universal Asset Management Co. Ltd. purchased a new stake in Tempus AI during the fourth quarter valued at $1,091,000. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Tempus AI by 1,591.2% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock valued at $68,922,000 after buying an additional 1,145,698 shares in the last quarter. Captrust Financial Advisors purchased a new position in Tempus AI in the third quarter worth about $2,726,000. Finally, Sigma Planning Corp bought a new stake in Tempus AI during the third quarter worth approximately $1,323,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms recently weighed in on TEM. Bank of America lifted their price objective on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, December 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a research report on Tuesday, January 14th. Loop Capital cut their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and increased their price target for the company from $45.00 to $65.00 in a report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, Tempus AI currently has a consensus rating of “Moderate Buy” and an average target price of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.